VERO NASDAQ
Venus Concept Inc.
1W: -7.7%
1M: -30.9%
3M: -79.5%
YTD: -79.5%
1Y: -86.2%
3Y: -99.2%
5Y: -99.9%
$0.31
Last traded 2026-04-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
19 relationships19
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-08-30
Earliest Filing
2025-10-02
Latest Filing
investor: 17
acquirer: 2
Counterparties (Filed by VERO)
19 relationshipsCompanies named in VERO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Madryn Health Partners, LP | — | investor | Holder of convertible notes exchanged for Series Y Preferred Stock and lender in bridge loan agreements | 2025-10-02 | View |
| Madryn Health Partners (Cayman Master), LP | — | investor | Holder of convertible notes exchanged for Series Y Preferred Stock and lender in bridge loan agreements | 2025-10-02 | View |
| Meta Robotics LLC | — | acquirer | Newly formed subsidiary of Venus Concept Inc. containing the Venus Hair Business portfolio. | 2025-06-06 | View |
| MHG Co., Ltd. | — | acquirer | Parent entity of Meta Healthcare Group acquiring the Venus Hair Business. | 2025-06-06 | View |
| Madryn Health Partners, LP | — | investor | Holder of convertible notes exchanged for new promissory notes and preferred stock | 2025-04-02 | View |
| Madryn Health Partners (Cayman Master), LP | — | investor | Holder of convertible notes exchanged for new promissory notes and preferred stock | 2025-04-02 | View |
| EW Healthcare Partners, L.P. | — | investor | Investor in the secured subordinated convertible notes. | 2025-03-04 | View |
| EW Healthcare Partners-A, L.P. | — | investor | Investor in the secured subordinated convertible notes. | 2025-03-04 | View |
| EW Healthcare Partners, L.P. | — | investor | Investor in $2,000,000 secured subordinated convertible notes | 2024-01-19 | View |
| EW Healthcare Partners-A, L.P. | — | investor | Investor in $2,000,000 secured subordinated convertible notes | 2024-01-19 | View |
| Madryn Health Partners, LP | — | investor | Holder of existing notes exchanging for new notes and preferred stock | 2023-10-05 | View |
| Madryn Health Partners (Cayman Master), LP | — | investor | Holder of existing notes exchanging for new notes and preferred stock | 2023-10-05 | View |
| EW Healthcare Partners, L.P. | — | investor | Investor in private placement of senior convertible preferred stock | 2023-07-12 | View |
| EW Healthcare Partners-A, L.P. | — | investor | Investor in private placement of senior convertible preferred stock | 2023-07-12 | View |
| EW Healthcare Partners, L.P. | — | investor | Investor in multi-tranche private placement of senior convertible preferred stock | 2023-05-15 | View |
| EW Healthcare Partners-A, L.P. | — | investor | Investor in multi-tranche private placement of senior convertible preferred stock | 2023-05-15 | View |
| Lincoln Park Capital Fund, LLC | — | investor | Entered into a purchase agreement to acquire up to $11,000,000 of Venus Concept Inc.'s common stock. | 2022-07-12 | View |
| Madryn Health Partners, LP | — | investor | Holds subordinated promissory notes with obligations reaffirmed in a Supplement to Subordination of Debt Agreements. | 2021-08-30 | View |
| Madryn Health Partners (Cayman Master), LP | — | investor | Holds subordinated promissory notes with obligations reaffirmed in a Supplement to Subordination of Debt Agreements. | 2021-08-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-02-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-01-21 | Entry into Material Definitive Agreement; Notice of Delisting or Transfer; Other Events; Financial S | Agreement | View |
| 2026-01-07 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-13 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-31 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-02 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2025-09-22 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-09-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-26 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Financial Statements and Exhibits | View | |
| 2025-08-06 | Entry into Material Definitive Agreement; Amendments to Articles of Incorporation or Bylaws; Financi | Agreement | View |
| 2025-07-25 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-07-01 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2025-06-26 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-06-09 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-06-06 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-28 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR